Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07336277 · ClinicalTrials.gov registry record · Phase 3
Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients
A Phase 3 study, sponsored by Emory University.
- Not yet
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT07336277 is a Phase 3 study that has not yet begun recruiting, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT07336277, a Phase 3 study, has not yet begun recruiting, sponsored by Emory University.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether a multimodal sleep pathway can enhance sleep quality in hospitalized patients with orthopedic trauma. It will also evaluate the effect of this pathway on opioid use and pain perception during recovery. The main study questions are: * Does the multimodal sleep pathway improve sleep quality and duration? * Does the pathway reduce the amount of opioids patients use during hospitalization? * Does improved sleep reduce pain interference with daily activities? Researchers will compare the multimodal sleep pathway to standard postoperative care to see if the pathway helps patients sleep better and rely less on opioids. Participants will: * Receive either the multimodal sleep pathway (zolpidem, melatonin, and sleep hygiene education) or standard care * Wear a wrist-worn actigraphy device to track sleep during their hospital stay * Complete daily questionnaires about sleep quality and pain
Interventions
- DIETARY_SUPPLEMENT Melatonin
- DRUG Zolpidem
- BEHAVIORAL Sleep Hygiene Education
- OTHER Standard Postoperative Care
- DEVICE Actigraph GT3X-BT Actigraph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07336277
The ClinicalTrials.gov registry entry for NCT07336277 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Melatonin is the first listed.
NCT07336277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07336277 about?
NCT07336277 is a clinical study titled "Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients". The goal of this study is to determine whether a multimodal sleep pathway can enhance sleep quality in hospitalized patients with orthopedic trauma. It will also evaluate the effect of this pathway on opioid use and pain perception during recovery. The main study questions are: * Does the multimod...
What is the current status of trial NCT07336277?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2026-06. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07336277?
The interventions under investigation include: Melatonin (DIETARY_SUPPLEMENT), Zolpidem (DRUG), Sleep Hygiene Education (BEHAVIORAL), Standard Postoperative Care (OTHER), Actigraph GT3X-BT Actigraph (DEVICE).
Who is sponsoring clinical trial NCT07336277?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.